The Study of Bisphosphonate and Postmenopausal Hormone Treatment in Low Bone Mineral Density / 대한골다공증학회지
Journal of Korean Society of Osteoporosis
;
: 132-138, 2011.
Article
Dans Coréen
| WPRIM
| ID: wpr-760749
ABSTRACT
OBJECTIVES:
To evaluate the effect of postmenopausal hormone therapy alone or in combination with bisphosphonate on bone mineral density (BMD) in postmenopausal women.METHODS:
One hundred three women diagnosed with low BMD in postmenopausal women were included in this study. All patients were classified into two groups; oarl hormone therpy alone (Group I) or with alendronate (Group II), given for 12 months. Dual energy X-ray absorptiometry was used to measure BMD before and after 12 months of treatment.RESULTS:
In all groups, significant increase in bone density measurements were seen at 12 months of treatment. The BMD of lumbar spine more increased significantly in Group II than Group I.CONCLUSIONS:
Postmenopausal hormone therapy is effective in osteopenic and osteoporotic women. However, the combined treatment with hormone therapy and bisphophonate is more effective in postmenopausal women with low BMD.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Rachis
/
Ménopause
/
Absorptiométrie photonique
/
Densité osseuse
/
Alendronate
Limites du sujet:
Femelle
/
Humains
langue:
Coréen
Texte intégral:
Journal of Korean Society of Osteoporosis
Année:
2011
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS